CAS No – 129453-61-8

Status – Pre-Validation

Product Description

Fulvestrant is a hormone therapy medication, specifically an estrogen receptor antagonist, used to treat hormone-receptor (HR) positive, HER2-negative advanced breast cancer in postmenopausal women. It works by blocking the action of estrogen on cancer cells, which can slow or stop the growth of some breast tumors that rely on estrogen to grow. It is administered as an intramuscular injection.